Brimonidine

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Brimonidine
Brimonidine.svg
Clinical data
Pronunciation /brɪˈmnɪdn/ bri-MOH-nid-een
Trade names Alphagan, Mirvaso, Lumify
AHFS/Drugs.com Consumer Drug Information
MedlinePlus a601232
License data
  • EU EMAby INN
Pregnancy
category
  • US: B (No risk in non-human studies)
Routes of
administration
topical (ophthalmic solution, gel)
ATC code
Legal status
Legal status
Pharmacokinetic data
Metabolism Primarily liver
Elimination half-life 3 hours (ocular), 12 hours (topical)
Identifiers
CAS Number
  • 59803-98-4 ☑Y
PubChem CID
  • 2435
IUPHAR/BPS
  • 520
DrugBank
  • DB00484 ☑Y
ChemSpider
  • 2341 ☑Y
UNII
  • E6GNX3HHTE
KEGG
  • D07540 ☑Y
ChEBI
  • CHEBI:3175 ☑Y
ChEMBL
  • CHEMBL844 ☑Y
ECHA InfoCard 100.149.042
Chemical and physical data
Formula C11H10BrN5
Molar mass 292.135 g/mol
3D model (JSmol)
  • Interactive image
Melting point 252 °C (486 °F)
  (verify)

Brimonidine is a drug, used as eye drops under the brand names Alphagan and Alphagan-P to treat open-angle glaucoma or ocular hypertension, as a gel, Mirvaso, for facial skin redness in rosacea, and in tartrate formulation, beginning in July 2018, as an ophthalmic vasoconstrictor, sold by Bausch and Lomb under the brand name Lumify, also as eye drops, in 0.025% solution.[citation needed]

It acts via decreasing synthesis of aqueous humor, and increasing the amount that drains from the eye through uveoscleral outflow; brimonidine treats reddened skin (erythema) by causing narrowing of blood vessels (vasoconstriction).

Clinical uses

Brimonidine is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It is also the active ingredient of Combigan along with timolol maleate.

A Cochrane Systematic Review compared the effect of brimonidine and timolol in slowing the progression of open angle glaucoma in adult participants.[1]

In 2013, the FDA approved topical application of brimonidine 0.33% gel (Mirvaso) for persistent facial redness of rosacea.

OTC eye drops ("Lumify")

In July 2018, Bausch and Lomb began to market OTC eye drops, using brimonidine's tartrate formulation in a concentration of 0.025%, as an ophthalmic vasoconstrictor under the brand name Lumify. Intended to relieve redness in the sclerae of the eyes for periods of up to eight hours at a time through its vasoconstrictive effects, Lumify was marketed as an alternative to Visine, the brand of tetrahydrozoline hydrochloride solution most commonly used for that purpose.

Mechanism of action

Brimonidine is an α2 adrenergic agonist.

α2 agonists, through the activation of a G protein-coupled receptor, inhibit the activity of adenylate cyclase. This reduces cAMP and hence aqueous humour production by the ciliary body.

Peripheral α2 agonist activity results in vasoconstriction of blood vessels (as opposed to central α2 agonist activity that decreases sympathetic tone, as can be seen by the medication clonidine). This vasoconstriction may explain the acute reduction in aqueous humor flow. The increased uveoscleral outflow from prolonged use may be explained by increased prostaglandin release due to α adrenergic stimulation. This may lead to relaxed ciliary muscle and increased uveoscleral outflow.[2]

References

  1. ^ Sena DF, Lindsley K (2017). "Neuroprotection for treatment of glaucoma in adults". Cochrane Database Syst Rev. 1: CD006539. doi:10.1002/14651858.CD006539.pub4. PMC 5370094. PMID 28122126.
  2. ^ Toris, C.; Camras, C.; Yablonski, M. (1999). "Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients". American Journal of Ophthalmology. 128 (1): 8–14. doi:10.1016/s0002-9394(99)00076-8. PMID 10482088.
  • Mosby's Drug Guide for Nurses (7th edition; Skidmore) 2007.

External links

  • Alphagan P (brimonidine tartrate ophthalmic solution) Product Website
  • Alphagan P Full Prescribing Information
  • Mirvaso (brimonidine topical gel) Product Website
Retrieved from "https://en.wikipedia.org/w/index.php?title=Brimonidine&oldid=868128811"
This content was retrieved from Wikipedia : http://en.wikipedia.org/wiki/Brimonidine
This page is based on the copyrighted Wikipedia article "Brimonidine"; it is used under the Creative Commons Attribution-ShareAlike 3.0 Unported License (CC-BY-SA). You may redistribute it, verbatim or modified, providing that you comply with the terms of the CC-BY-SA